
Commentary|Videos|March 10, 2022
What Pharmacists Should Understand When Assessing, Treating Patients With Ovarian Cancer With Rucaparib
Thomasina Morris, RPh, MHA, BCOP, pharmacist at Moffitt Cancer Center, discusses what oncology pharmacists should understand about rucaparib when treating ovarian cancer.
Advertisement
Pharmacy Times interviewed Thomasina Morris, RPh, MHA, BCOP, pharmacist at Moffitt Cancer Center, on what rucaparib is used to treat and how its mechanism of action works to fight cancer.
During the interview, Morris addressed what oncology pharmacists should understand when assessing and treating patients with ovarian cancer with rucaparib.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FAQ: Guidance for Pharmacists, SSRIs Under Scrutiny and Political Debate
2
Q&A: Pharmacy Technicians and the Future of Obesity Management
3
GLP-1 Receptor Agonists Linked to Improved Survival Outcomes in Breast Cancer
4
How Clinical Pharmacists Optimize Obstructive Hypertrophic Cardiomyopathy Care
5


































































































































